Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) traded down 20% during trading on Thursday . The stock traded as low as C$1.24 and last traded at C$1.24. 500 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 8,000 shares. The stock had previously closed at C$1.55.
Genscript Biotech Stock Down 20.0 %
The company has a 50 day moving average of C$1.31 and a 200 day moving average of C$1.41.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- 3 Warren Buffett Stocks to Buy Now
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Use the MarketBeat Stock Screener
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Using the MarketBeat Dividend Yield Calculator
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
